Biosimilars to usher new growth, lead $1 trillion drug exports by 2030

India's pharmaceutical industry is targeting $1 trillion in drug exports by 2030, with biosimilars expected to be a major growth driver. The biosimilars market could exceed $60 billion by 2030, supported by Indian firms investing in biologics and advanced markets. Achieving this ambitious goal requires collaboration and a focus on innovation-driven categories.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/pyYO9Eq
via IFTTT